_targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy
- PMID: 17560117
- DOI: 10.1016/j.critrevonc.2007.04.010
_targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy
Abstract
Sphingolipids not only function as structural components of cell membranes but also act as signaling molecules to regulate fundamental cellular responses, such as cell death and differentiation, proliferation and certain types of inflammation. Particularly the cellular balance between ceramide and sphingosine 1-phosphate seems to be crucial for a cell's decision to either undergo apoptosis or proliferate, two events which are implicated in tumor development and growth. Whereas ceramide possesses proapoptotic capacity in many cell types, sphingosine 1-phosphate acts as a counterplayer able to induce cell proliferation and protect cells from undergoing apoptosis. Therefore, tipping the balance in favour of ceramide production, i.e. by inhibiting ceramidase or sphingosine kinase activities has potential to support its proapoptotic action and hence represents a promising rational approach to effective cancer therapy. This review highlights most recent data on the regulation of cellular sphingolipid formation and their potential implication in tumor development, and provides perspectives for their use as _targets in molecular intervention therapy.
Similar articles
-
Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.Curr Pharm Des. 2006;12(35):4625-35. doi: 10.2174/138161206779010422. Curr Pharm Des. 2006. PMID: 17168766
-
Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.Prog Lipid Res. 2010 Oct;49(4):316-34. doi: 10.1016/j.plipres.2010.02.004. Epub 2010 Mar 1. Prog Lipid Res. 2010. PMID: 20193711 Review.
-
The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.Comp Biochem Physiol B Biochem Mol Biol. 2012 Sep;163(1):26-36. doi: 10.1016/j.cbpb.2012.05.006. Epub 2012 May 18. Comp Biochem Physiol B Biochem Mol Biol. 2012. PMID: 22613819 Review.
-
Sphingolipid metabolizing enzymes as novel therapeutic _targets.Subcell Biochem. 2008;49:487-522. doi: 10.1007/978-1-4020-8831-5_19. Subcell Biochem. 2008. PMID: 18751924 Review.
-
Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.Prog Lipid Res. 2007 Mar;46(2):126-44. doi: 10.1016/j.plipres.2007.03.001. Epub 2007 Mar 14. Prog Lipid Res. 2007. PMID: 17449104 Review.
Cited by
-
_targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis.PLoS One. 2012;7(6):e39209. doi: 10.1371/journal.pone.0039209. Epub 2012 Jun 25. PLoS One. 2012. PMID: 22761740 Free PMC article.
-
A prokaryotic S1P lyase degrades extracellular S1P in vitro and in vivo: implication for treating hyperproliferative disorders.PLoS One. 2011;6(8):e22436. doi: 10.1371/journal.pone.0022436. Epub 2011 Aug 1. PLoS One. 2011. PMID: 21829623 Free PMC article.
-
The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug _target.Int J Mol Sci. 2020 May 17;21(10):3544. doi: 10.3390/ijms21103544. Int J Mol Sci. 2020. PMID: 32429572 Free PMC article. Review.
-
Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma.Neuro Oncol. 2012 Apr;14(4):405-15. doi: 10.1093/neuonc/nos005. Epub 2012 Feb 20. Neuro Oncol. 2012. PMID: 22351749 Free PMC article.
-
LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria.J Pharmacol Exp Ther. 2013 Jan;344(1):167-78. doi: 10.1124/jpet.112.199216. Epub 2012 Oct 18. J Pharmacol Exp Ther. 2013. PMID: 23086228 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
